Inpart
Robin K. is currently the Chief Product Officer at Inova.io, where they oversee product strategy and development across the suite of solutions offered for biopharma partnering excellence. Robin is also the Co-Founder and Director at IN-PART, where they strategically match private sector businesses with university research outputs. In the past, Robin served as an Honorary Research Associate and Postdoctoral Research Associate at King's College London, focusing on enterovirus infection in Type 1 diabetes. Additionally, Robin worked as a Microbiologist at Ecolab, where they maintained relationships with clients in a contract-based quality control facility. Robin holds a PhD in Immunology from King's College London and a BSc in Microbiology and Immunology from the University of Leeds.
This person is not in any offices
Inpart
1 followers
Inpart is the leading global platform for science partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations. Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.